Kwality Pharmaceuticals Limited (BOM:539997)

Market Cap	14.13B +57.1%
Revenue (ttm)	4.62B +24.2%
Net Income	565.34M +69.4%
EPS	54.54 +69.4%
Shares Out	10.38M
PE Ratio	24.97
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	251,784
Average Volume	24,713
Open	1,150.00
Previous Close	1,147.50
Day's Range	1,150.00 - 1,377.00
52-Week Range	596.05 - 1,362.00
Beta	-0.25
RSI	73.36
Earnings Date	Feb 2, 2026

About Kwality Pharmaceuticals

Kwality Pharmaceuticals Limited, together with its subsidiary, manufactures finished pharmaceutical formulations in India and internationally. The company offers its products in various dosage forms, including liquid orals, powder for oral suspension, dry syrups, tablets, capsules, sterile powder for injections, small volume parentals (liquid and lyophilized), pre filled syringes, ointments and creams, ophthalmic preparations, eye/ear drops, sanitizers, suppositories, injectable vials and ampoules, lyophilized products, syrups, daunorubicin, an...

• Industry: Pharmaceutical Preparations
• Founded: 1983
• Employees: 997
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 539997

Financial Performance

In fiscal year 2025, Kwality Pharmaceuticals's revenue was 3.70 billion, an increase of 20.52% compared to the previous year's 3.07 billion. Earnings were 398.45 million, an increase of 67.44%.